Lineage Cell Therapeutics Inc - Company Profile
Powered by 
All the data and insights you need on Lineage Cell Therapeutics Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Lineage Cell Therapeutics Inc Strategy Report
- Understand Lineage Cell Therapeutics Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Lineage Cell Therapeutics Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| EP4351334A1 | Application | Verfahren und zusammensetzungen zur behandlung von netzhauterkrankungen und -leiden | A61B3/0025; A61B3/102; A61B3/12; A61B3/14; A61P25/16; A61P3/10; C12N2506/02; C12N5/0621; G16H20/10; G16H20/40; G16H30/40; G16H50/20 | April 17, 2024 |
| KR1020240038013A | Application | 망막 색소 상피 세포의 확장 | A61K35/30; A61P27/02; C12N2500/02; C12N2500/38; C12N2501/15; C12N2501/16; C12N2506/02; C12N2531/00; C12N2533/52; C12N2533/54; C12N2533/90; C12N5/0621 | March 22, 2024 |
| US20240082311A1 | Application | Compositions and methods for treating spinal cord injuries | C12N2500/38; C12N2501/155; C12N2501/727; C12N2506/02; C12N5/0622; A61K35/30; A61K9/0019; A61K9/0085; A61P25/00 | March 14, 2024 |
| US11920155B2 | Grant | Oligodendrocyte progenitor cell compositions | C12N5/0622; A61K35/30 | March 05, 2024 |
| IL310156A | Application | Expansion of retinal pigment epithelium cells | A61K35/30; A61P27/02; C12N2500/02; C12N2500/38; C12N2501/15; C12N2501/16; C12N2506/02; C12N2531/00; C12N2533/52; C12N2533/54; C12N2533/90; C12N5/0621 | March 01, 2024 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer